نمایش مختصر رکورد

dc.contributor.authorDadpour, Bitaen_US
dc.contributor.authorShafahi, Azamen_US
dc.contributor.authorMonzavi, Seyeden_US
dc.contributor.authorZavar, Abbasen_US
dc.contributor.authorAfshari, Rezaen_US
dc.contributor.authorKhoshdel, Alien_US
dc.date.accessioned1399-07-09T12:22:34Zfa_IR
dc.date.accessioned2020-09-30T12:22:35Z
dc.date.available1399-07-09T12:22:34Zfa_IR
dc.date.available2020-09-30T12:22:35Z
dc.date.issued2012-12-01en_US
dc.date.issued1391-09-11fa_IR
dc.date.submitted2012-09-08en_US
dc.date.submitted1391-06-18fa_IR
dc.identifier.citationDadpour, Bita, Shafahi, Azam, Monzavi, Seyed, Zavar, Abbas, Afshari, Reza, Khoshdel, Ali. (2012). Snakebite Prognostic Factors: Leading Factors of Weak Therapeutic Response Following Snakebite Envenomation. Asia Pacific Journal of Medical Toxicology, 1(1), 27-33. doi: 10.22038/apjmt.2012.42en_US
dc.identifier.issn2322-2611
dc.identifier.issn2322-4320
dc.identifier.urihttps://dx.doi.org/10.22038/apjmt.2012.42
dc.identifier.urihttp://apjmt.mums.ac.ir/article_42.html
dc.identifier.urihttps://iranjournals.nlai.ir/handle/123456789/420801
dc.description.abstract<em>Background:</em> The goal of antivenom administration for snake-bitten patients is to achieve therapeutic response (initial control), which means reversal of the venom-induced effects through neutralizing the venom. The aim of this study was to identify snakebite prognostic factors of weak therapeutic response prior to antivenom administration. <br/><em>Methods:</em> This was a retrospective study of patients with viperidae snakebite envenomation who were admitted to Mashhad Toxicology Centre during 2007-2011. Demographic features, clinical manifestations and snakebite severity score (SSS) were collected prior to antivenom administration. Total number of antivenom vials administered to achieve therapeutic response and duration of hospitalization were also recorded. Potential factors in snakebite prognosis were analyzed by comparing in two groups of achieving therapeutic response with less than 5 vials and over 5 to calculate odds ratio.  <br/><em>Results:</em> Total of 108 patients (male/female: 85/23) with mean (SD) age of 34.5 (17.0) were studied. The most common manifestations included fang marks (100%), pain (100%), ecchymosis (89%), swelling (83%), blister formation (48%) and thrombocytopenia (25%). In univariate analysis, thrombocytopenia (P=0.01), spontaneous bleeding (P=0.02), coagulopathic disturbances (P=0.007), swelling (P=0.003), progressive swelling (P=0.005), ecchymosis (P=0.05) and respiratory distress (P= 0.05) were significantly correlated to weak therapeutic response. Swelling and spontaneous bleeding were the strongest snakebite prognostic factors, as respectively they put the patients at 12.4 and 10.4 fold risks for difficult achievement of therapeutic response. <br/><em>Conclusions:</em> In snakebite, some clinical manifestations in the first hours of admission and prior to antivenom administration are associated with weak therapeutic response. Identifying these prognostic factors, can assist health care providers to better estimate the patient's needs and predict the final consequences.en_US
dc.format.extent1751
dc.format.mimetypeapplication/pdf
dc.languageEnglish
dc.language.isoen_US
dc.publisherMashhad University of Medical Sciencesen_US
dc.relation.ispartofAsia Pacific Journal of Medical Toxicologyen_US
dc.relation.isversionofhttps://dx.doi.org/10.22038/apjmt.2012.42
dc.subjectSnakebiteen_US
dc.subjectPrognostic factoren_US
dc.subjectThrombocytopeniaen_US
dc.subjectTherapeutic responseen_US
dc.subjectInitial controlen_US
dc.titleSnakebite Prognostic Factors: Leading Factors of Weak Therapeutic Response Following Snakebite Envenomationen_US
dc.typeTexten_US
dc.typeOriginal Articleen_US
dc.contributor.departmentAddiction Research Centre, Mashhad University of Medical Sciences, Mashhad, Iranen_US
dc.contributor.departmentDepartment of infectious diseases, Intensive care unit, Mashhad University of Medical Sciences, Mashhad, Iranen_US
dc.contributor.departmentAddiction Research Centre, Mashhad University of Medical Sciences, Mashhad, Iran. AJA University of Medical Sciences, Tehran, Iranen_US
dc.contributor.departmentAddiction Research Centre, Mashhad University of Medical Sciences, Mashhad, Iranen_US
dc.contributor.departmentAddiction Research Centre, Mashhad University of Medical Sciences, Mashhad, Iranen_US
dc.contributor.departmentAJA University of Medical Sciences, Tehran, Iranen_US
dc.citation.volume1
dc.citation.issue1
dc.citation.spage27
dc.citation.epage33


فایل‌های این مورد

Thumbnail

این مورد در مجموعه‌های زیر وجود دارد:

نمایش مختصر رکورد